These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21771831)

  • 1. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care.
    Rodríguez LA; Cea-Soriano L; Martín-Merino E; Johansson S
    BMJ; 2011 Jul; 343():d4094. PubMed ID: 21771831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between low-dose acetylsalicylic acid reinitiation and the risk of myocardial infarction or coronary heart disease death.
    Sáez ME; González-Pérez A; Johansson S; Himmelmann A; García Rodríguez LA
    Eur J Prev Cardiol; 2016 Jul; 23(10):1029-36. PubMed ID: 26603743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
    García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
    Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antiplatelet drugs in the prevention of cardiovascular events.
    Tendera M; Wojakowski W
    Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.
    Timmis A; Rapsomaniki E; Chung SC; Pujades-Rodriguez M; Moayyeri A; Stogiannis D; Shah AD; Pasea L; Denaxas S; Emmas C; Hemingway H
    BMJ; 2016 Jun; 353():i3163. PubMed ID: 27334486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.
    Roshandel G; Khoshnia M; Poustchi H; Hemming K; Kamangar F; Gharavi A; Ostovaneh MR; Nateghi A; Majed M; Navabakhsh B; Merat S; Pourshams A; Nalini M; Malekzadeh F; Sadeghi M; Mohammadifard N; Sarrafzadegan N; Naemi-Tabiei M; Fazel A; Brennan P; Etemadi A; Boffetta P; Thomas N; Marshall T; Cheng KK; Malekzadeh R
    Lancet; 2019 Aug; 394(10199):672-683. PubMed ID: 31448738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
    Stefanescu Schmidt AC; Kereiakes DJ; Cutlip DE; Yeh RW; D'Agostino RB; Massaro JM; Hsieh WH; Mauri L;
    Circulation; 2017 May; 135(18):1720-1732. PubMed ID: 28228427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation.
    Cea Soriano L; Bueno H; Lanas A; García Rodríguez LA
    Thromb Haemost; 2013 Dec; 110(6):1298-304. PubMed ID: 24008261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of aspirin use and primary prevention of cardiovascular disease in women.
    Manson JE; Stampfer MJ; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    JAMA; 1991 Jul 24-31; 266(4):521-7. PubMed ID: 2061978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
    Mehta SR; Yusuf S; Peters RJ; Bertrand ME; Lewis BS; Natarajan MK; Malmberg K; Rupprecht H; Zhao F; Chrolavicius S; Copland I; Fox KA;
    Lancet; 2001 Aug; 358(9281):527-33. PubMed ID: 11520521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
    Jones WS; Mulder H; Wruck LM; Pencina MJ; Kripalani S; Muñoz D; Crenshaw DL; Effron MB; Re RN; Gupta K; Anderson RD; Pepine CJ; Handberg EM; Manning BR; Jain SK; Girotra S; Riley D; DeWalt DA; Whittle J; Goldberg YH; Roger VL; Hess R; Benziger CP; Farrehi P; Zhou L; Ford DE; Haynes K; VanWormer JJ; Knowlton KU; Kraschnewski JL; Polonsky TS; Fintel DJ; Ahmad FS; McClay JC; Campbell JR; Bell DS; Fonarow GC; Bradley SM; Paranjape A; Roe MT; Robertson HR; Curtis LH; Sharlow AG; Berdan LG; Hammill BG; Harris DF; Qualls LG; Marquis-Gravel G; Modrow MF; Marcus GM; Carton TW; Nauman E; Waitman LR; Kho AN; Shenkman EA; McTigue KM; Kaushal R; Masoudi FA; Antman EM; Davidson DR; Edgley K; Merritt JG; Brown LS; Zemon DN; McCormick TE; Alikhaani JD; Gregoire KC; Rothman RL; Harrington RA; Hernandez AF;
    N Engl J Med; 2021 May; 384(21):1981-1990. PubMed ID: 33999548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Yu J; Mehran R; Dangas GD; Claessen BE; Baber U; Xu K; Parise H; Fahy M; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
    JACC Cardiovasc Interv; 2012 Dec; 5(12):1231-8. PubMed ID: 23257371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.